Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
958.4 INR | -0.42% | +1.82% | +12.24% |
Sales 2024 * | 121B 1.45B | Sales 2025 * | 139B 1.67B | Capitalization | 272B 3.26B |
---|---|---|---|---|---|
Net income 2024 * | 18.78B 225M | Net income 2025 * | 11.13B 133M | EV / Sales 2024 * | 2.4 x |
Net Debt 2024 * | 19.51B 234M | Net cash position 2025 * | 2.88B 34.56M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
39.9
x | P/E ratio 2025 * |
23.8
x | Employees | 15,556 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.29% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | -0.42% | ||
1 week | +1.24% | ||
Current month | +3.61% | ||
1 month | +5.19% | ||
3 months | +12.05% | ||
6 months | +23.36% | ||
Current year | +12.24% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Director/Board Member | 51 | 05-04-25 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 115 M€ | +4.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 958.4 | -0.42% | 517 943 |
24-03-27 | 962.4 | +0.55% | 752,945 |
24-03-26 | 957.2 | +0.65% | 685,483 |
24-03-22 | 951 | +0.45% | 792,841 |
24-03-21 | 946.7 | +0.57% | 721,888 |
Delayed Quote NSE India S.E., March 28, 2024 at 06:22 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.24% | 3.26B | |
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
-0.67% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.37% | 5.14B |